Indian Kanoon - Search engine for Indian Law

7. Heard ld. Counsels for the parties. The present case relates to the pharmaceutical preparation containing 'ibuprufen' and 'paracetamol'. The Plaintiff claims rights in the mark 'COMBIFLAM', which is one of the leading pain killer medicines available in the market. The Plaintiff is the proprietor of the mark 'COMBIFLAM', registered in favour of the Plaintiff both as a word mark and as a label mark, since 22nd August, 1984, vide Registration No.426051 in Class 5 for "medicinal and pharmaceutical preparations". It was adopted in the year 1984 and has since then been used extensively in India. The mark is currently valid and renewed up to August 22, 2025. Plaintiff has also secured registration for the trademarks 'COMBIFLAM VET', ' ' and 'COMBIFLAM, PAIN GONE, ZINDAGI (LIFE) ON' under Registration Nos. 2747470, 3320487 and 3559775 in Class 5.

3. In 2009, the plaintiff also launched its product COMBIFLAM Cream. In 2013, the plaintiff launched its product COMBIFLAM PLUS tablets, a formulation of paracetamol and caffeine. In 2014, the plaintiff applied for registration of 'COMBIFLAM VET' in Class 5 for veterinary preparations and substances in India. In 2016, the plaintiff applied for registration of the mark in Class 5 for pharmaceutical preparations; pain relief product in India.